Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C

NCT01121185 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped The study was terminated due to slower than anticipated subject accrual.

Conditions

HCV Infection
Liver Transplantation

Interventions

BIOLOGICAL: MBL-HCV1
OTHER: 0.9% Sodium chloride Placebo

Sponsor

MassBiologics